Medipattern mHealth Ships Units to Radiology Practice

Attention: Business/Financial Editors

The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), an award-winning
leader in the development and commercialization of healthcare solutions that
positively impact people's lives through the prevention of disease and analysis
of medical images and data, announced today that its mHealth Business Unit has
shipped SMARTCOACH(TM) to Zwanger-Pesiri Radiology, one of the largest private
radiology practices in New York. The practice is providing SMARTCOACH to its 600
employees to guide them toward their fitness and health goals. Zwanger-Pesiri is
a leader in offering ground breaking imaging technology, innovative patient
care, and commitment to the wellness of its employees. 


"Zwanger-Pesiri has a strong relationship with Medipattern through both the
B-CAD(R) program and now Visualize:Vascular(TM). When Medipattern introduced us
to the SMARTCOACH system, we were immediately impressed. SMARTCOACH is not a
step counter. It is a health coach that guides you to achieve both fitness and
health goals. It monitors individuals to see the intensity of their activity and
coaches them toward obtaining their individual goals. SMARTCOACH has a wearable
component which actively lets you see if you are achieving your goals in real
time and then it coaches you. It logs your activity showing you times where you
can improve and suggests activities that can get the most out of your activity.
It coaches all of us individually on fitness, nutrition and health making
meaningful suggestions to each of us. SMARTCOACH also allows us to create a
circle of care, where we can message each individual or groups of users within
our private group to help motivate them and keep them on track," commented Dr.
Steven Mendelsohn, president of Zwanger-Pesiri Radiology. 


"Radiologists see that Metabolic Syndrome is growing at an alarming rate. The
syndrome's key indicators are obesity or extra weight around the middle, high
blood pressure, high triglycerides, and low HDL. We know the long term effects
are increased risk to Type 2 Diabetes, Cardiovascular Disease and Stroke all of
which impact a person's quality of life years before causing death. The main way
to combat the syndrome is with diet and exercise. We generally site these
concerns when reviewing patients, but we also need to look at ourselves. That is
why we are joining the SMARTCOACH program and giving the device to everyone on
our staff who will commit to making a change to live better. The next step will
be engaging our patients to become proactive in preventing Metabolic Syndrome to
get them moving towards a healthier future," concluded Dr. Mendelsohn.


"Zwanger-Pesiri brings outstanding care to their community with leading edge
imaging technologies and innovative wellness programs. We are very pleased to be
a part of their upcoming Wellness Fair on September 30th carrying their message
about fitness and health to their community," commented Jeff Collins, CEO of
Medipattern. "We are also very pleased to be partnering with Zwanger-Pesiri to
address the most rapidly growing health problem in the United States: Metabolic
Syndrome. Everyone at Zwanger-Pesiri will be participating in the SMARTCOACH
program. The data will be used to report on the benefits of SMARTCOACH, allowing
us to demonstrate its benefits to much larger groups and other practices."


About the Medipattern Corporation: 

Medipattern(R) is an award-winning leader in the development and
commercialization of healthcare solutions that positively impact people's lives
through the prevention of disease and analysis of medical images and data.
Medipattern's Knowledge-based Informatics (MKI) platform enables delivery of
these streamlined solutions. Medipattern mHealth uses patented prevention
technologies to engage, coach and monitor people in achieving their personalized
goals. Medipattern iaHealth uses patented pattern recognition technology to
analyze medical data to aid medical practitioners in the assessment of disease
and critical anatomy. For more information, please visit the Company's website:
www.medipattern.com.


Medipattern(R) and B-CAD(R) are registered trademarks of The Medipattern
Corporation. Visualize:Vascular(TM) is a registered trademark of Medipattern and
SMARTCOACH(TM) is a trademark of MYTRAK Health Systems and will be under
temporary license to Medipattern while the company reviews branding.


Forward-looking statements 

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates,'' "believes,'' "estimates,'' "expects,'' "plans,'' "intends,''
"potential'', and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings, (posted at www.sedar.com). These factors should be
considered carefully, and readers should not place undue reliance on
Medipattern's forward-looking statements. In addition, these forward-looking
statements relate to the date on which they are made. The Company disclaims any
intention or obligation to update or revise any forward-looking statements for
any reason. Readers should not rely on forward-looking statements.